Xiaoguang Dou

机构：China Medical University · ORCID：0000-0003-1856-7331

发表论文 164 篇 · 总被引 3535 次 · h-index 27

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 34)
• High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy (2024 · Gut · 被引 27)
• Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis (2024 · Hepatology International · 被引 17)
• Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis (2025 · Hepatology International · 被引 14)
• SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradation (2025 · Nature Communications · 被引 9)
• Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial (2025 · Hepatology International · 被引 8)